Published in PLoS One on May 14, 2008
Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke (2010) 2.29
Post-stroke infection: a systematic review and meta-analysis. BMC Neurol (2011) 2.29
The immunology of acute stroke. Nat Rev Neurol (2012) 2.06
Retracted Systematic study of cilostazol on secondary stroke prevention: a meta-analysis. Eur J Med Res (2013) 1.49
Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care (2010) 1.48
Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One (2012) 1.13
CNS immune responses following experimental stroke. Neurocrit Care (2009) 1.11
A role for spleen monocytes in post-ischemic brain inflammation and injury. J Neuroinflammation (2010) 1.10
Post-stroke infection: a role for IL-1ra? Neurocrit Care (2011) 1.03
Infection after acute ischemic stroke: risk factors, biomarkers, and outcome. Stroke Res Treat (2011) 1.01
Infection after intracerebral hemorrhage: risk factors and association with outcomes in the ethnic/racial variations of intracerebral hemorrhage study. Stroke (2014) 0.95
Immune interventions in stroke. Nat Rev Neurol (2015) 0.94
Modulation of the postischemic immune response to improve stroke outcome. Stroke (2010) 0.93
Damage control in the nervous system: beware the immune system in spinal cord injury. Nat Med (2009) 0.93
Therapeutic hypothermia in stroke and traumatic brain injury. Front Neurol (2011) 0.91
Do stroke models model stroke? Dis Model Mech (2012) 0.91
Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone. Neuroscience (2012) 0.91
The Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review. Aging Dis (2014) 0.90
Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke. J Neuroinflammation (2014) 0.88
Traumatic brain injury-induced alterations in peripheral immunity. J Trauma Acute Care Surg (2013) 0.88
Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection. J Neuroinflammation (2015) 0.88
The SCIentinel study--prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS)--study protocol and interim feasibility data. BMC Neurol (2013) 0.86
Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach. J Cereb Blood Flow Metab (2013) 0.84
Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus. Front Neurol (2015) 0.83
Effect of Antibiotic Class on Stroke Outcome. Stroke (2015) 0.83
External validation of the A2DS2 score to predict stroke-associated pneumonia in a Chinese population: a prospective cohort study. PLoS One (2014) 0.82
Ischemia, Immunosuppression and Infection-Tackling the Predicaments of Post-Stroke Complications. Int J Mol Sci (2016) 0.80
Correlation between inflammatory factors and post-stroke pneumonia in diabetic patients. Exp Ther Med (2013) 0.78
High natural killer cell number might identify stroke patients at risk of developing infections. Neurol Neuroimmunol Neuroinflamm (2015) 0.78
A novel SPECT-based approach reveals early mechanisms of central and peripheral inflammation after cerebral ischemia. J Cereb Blood Flow Metab (2015) 0.77
Long-term functional outcome in patients with acquired infections after acute spinal cord injury. Neurology (2017) 0.76
Study protocol: prediction of stroke associated infections by markers of autonomic control. BMC Neurol (2014) 0.76
Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan. Trials (2014) 0.76
Can prophylactic antibiotics for aspiration improve stroke outcomes? The PANTHERIS trial. J Pak Med Assoc (2014) 0.75
Is early clinical evidence of autonomic shift predictive of infection after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis (2013) 0.75
Central fever in patients with spontaneous intracerebral hemorrhage: predicting factors and impact on outcome. BMC Neurol (2015) 0.75
Reduction of the systemic inflammatory induced by acute cerebral infarction through ultra-early thrombolytic therapy. Exp Ther Med (2015) 0.75
The Efficacy of Prophylactic Antibiotics on Post-Stroke Infections: An Updated Systematic Review and Meta-Analysis. Sci Rep (2016) 0.75
Immunomodulation after ischemic stroke: potential mechanisms and implications for therapy. Crit Care (2016) 0.75
Total time of operation is a risk factor of stroke-associated pneumonia in acute ischemic stroke patients with intra-arterial treatment. Medicine (Baltimore) (2016) 0.75
The role of the immunoinflammatory response after cardiac arrest. Arch Med Sci (2011) 0.75
Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. BMC Neurol (2016) 0.75
Treatment of fever after stroke: conflicting evidence. Pharmacotherapy (2011) 0.75
Potential specific immunological indicators for stroke associated infection are partly modulated by sympathetic pathway activation. Oncotarget (2016) 0.75
Preventive Ceftriaxone in Patients with Stroke Treated with Intravenous Thrombolysis: Post Hoc Analysis of the Preventive Antibiotics in Stroke Study. Cerebrovasc Dis (2016) 0.75
The contribution of antibiotics, pneumonia and the immune response to stroke outcome. J Neuroimmunol (2016) 0.75
Monocyte-lymphocyte cross-communication via soluble CD163 directly links innate immune system activation and adaptive immune system suppression following ischemic stroke. Sci Rep (2017) 0.75
Validation of risk scoring models for predicting stroke-associated pneumonia in patients with ischaemic stroke. Stroke Vasc Neurol (2016) 0.75
FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J (1965) 38.57
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Measurements of acute cerebral infarction: a clinical examination scale. Stroke (1989) 14.54
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis (2000) 7.80
Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther (1974) 7.08
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med (1997) 5.19
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med (2003) 3.89
Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet (2005) 3.64
Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke (2003) 3.53
Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci (2005) 3.45
Medical complications after stroke: a multicenter study. Stroke (2000) 2.81
Formal dysphagia screening protocols prevent pneumonia. Stroke (2005) 2.78
Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke (2007) 2.76
Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med (1978) 2.65
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med (2006) 2.56
The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology (2003) 2.36
Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke (1998) 2.22
Complications after acute stroke. Stroke (1996) 2.21
Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med (2004) 2.16
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12
Early predictors of death and disability after acute cerebral ischemic event. Stroke (1995) 2.04
Quantitative aspiration during sleep in normal subjects. Chest (1997) 1.98
Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke (2005) 1.91
Timing for fever-related brain damage in acute ischemic stroke. Stroke (1998) 1.68
Dysphagia therapy following stroke: a controlled trial. Neurology (1994) 1.66
Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol (2004) 1.65
Screening for dysphagia and aspiration in acute stroke: a systematic review. Dysphagia (2001) 1.58
Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci (2006) 1.49
Diagnosis and treatment of ventilator-associated pneumonia. Chest (2006) 1.45
The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke (2005) 1.44
Cause-specific mortality after first cerebral infarction: a population-based study. Stroke (2003) 1.39
Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke (2006) 1.39
Relation between incidence of pneumonia and protective reflexes in post-stroke patients with oral or tube feeding. J Intern Med (2000) 1.22
Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke (2003) 1.21
Swallowing disorders post orotracheal intubation in the elderly. Intensive Care Med (2003) 1.18
Fever and infection early after ischemic stroke. J Neurol Sci (1999) 1.16
Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry (2004) 1.08
Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother (2002) 1.02
Established treatments for acute ischaemic stroke. Lancet (2007) 1.02
Very low monocytic HLA-DR expression indicates high risk of infection--immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. Eur J Emerg Med (1995) 1.00
Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytometry B Clin Cytom (2003) 0.99
Intermittent oro-esophageal tube feeding in acute stroke patients -- a pilot study. Acta Neurol Scand (2006) 0.93
Acute treatment of ischaemic stroke. European Stroke Initiative. Cerebrovasc Dis (2004) 0.90
The predictors of early infection after an acute ischaemic stroke. Singapore Med J (2003) 0.90
In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria. Int J Antimicrob Agents (2000) 0.86
Clinical characteristics and functional outcome of stroke patients 75 years old and older. Arch Phys Med Rehabil (1998) 0.85
Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med (2009) 4.98
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol (2006) 4.88
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med (2003) 3.89
Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke (2008) 3.87
Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet (2010) 3.60
Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci (2005) 3.45
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol (2006) 3.24
The lymphocyte transformation test for borrelia detects active lyme borreliosis and verifies effective antibiotic treatment. Open Neurol J (2012) 2.99
Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke (2008) 2.98
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol (2009) 2.98
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J (2005) 2.92
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study. Lancet (2008) 2.77
MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem (2001) 2.76
Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke (2007) 2.76
A circadian clock in macrophages controls inflammatory immune responses. Proc Natl Acad Sci U S A (2009) 2.71
Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol (2002) 2.54
Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev (2003) 2.52
Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med (2002) 2.52
Terminally differentiated CD8⁺ T cells negatively affect bone regeneration in humans. Sci Transl Med (2013) 2.43
Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis (2002) 2.33
Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med (2005) 2.28
Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med (2009) 2.28
Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis (2008) 2.26
Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ Res (2006) 2.21
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. J Am Coll Cardiol (2012) 2.11
Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke. Stroke (2007) 2.10
Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain (2009) 2.06
The immunology of acute stroke. Nat Rev Neurol (2012) 2.06
Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One (2007) 2.05
Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci (2002) 2.05
Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur J Immunol (2006) 2.04
Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke (2002) 2.00
MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut (2010) 1.93
Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain. Proc Natl Acad Sci U S A (2010) 1.91
The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med (2004) 1.90
How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med (2005) 1.87
Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers. Pharmacogenetics (2002) 1.85
Transcriptional profiling of Helicobacter pylori Fur- and iron-regulated gene expression. Microbiology (2005) 1.85
Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol (2007) 1.85
IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J Immunol (2007) 1.80
Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol (2011) 1.77
IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) (2009) 1.76
Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood (2003) 1.76
Controlled growth of tetrapod-branched inorganic nanocrystals. Nat Mater (2003) 1.76
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol (2005) 1.74
Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem (2005) 1.74
Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA-A*0201. J Immunol (2004) 1.68
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J Hypertens (2007) 1.68
Mechanisms of stroke protection by physical activity. Ann Neurol (2003) 1.67
The Helicobacter pylori homologue of the ferric uptake regulator is involved in acid resistance. Infect Immun (2002) 1.65
Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke (2003) 1.65
Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients. Crit Care Med (2009) 1.64
Myocardial function in older male amateur marathon runners: assessment by tissue Doppler echocardiography, speckle tracking, and cardiac biomarkers. J Am Soc Echocardiogr (2009) 1.63
Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One (2012) 1.63
Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology (2002) 1.62
Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation (2003) 1.61
Pathophysiology of stroke: lessons from animal models. Metab Brain Dis (2004) 1.61
Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J Exp Med (2008) 1.61
Tuberculin-specific T cells are reduced in active pulmonary tuberculosis compared to LTBI or status post BCG vaccination. J Infect Dis (2010) 1.58
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin Pharmacol Ther (2002) 1.58
Role of glial cells in cerebral ischemia. Glia (2005) 1.58
Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation. Kidney Int (2013) 1.54
The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol (2011) 1.54
Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J (2005) 1.54
Immune privilege of endothelial cells differentiated from endothelial progenitor cells. Cardiovasc Res (2010) 1.53
Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology (2003) 1.52
Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol (2007) 1.48
Reprint: Good laboratory practice: preventing introduction of bias at the bench. J Cereb Blood Flow Metab (2008) 1.47
Low immunogenicity of endothelial derivatives from rat embryonic stem cell-like cells. Cell Res (2009) 1.46
Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant (2009) 1.44
The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One (2010) 1.44
Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab (2002) 1.44
Immunopathogenesis of psoriasis. Exp Dermatol (2007) 1.44
The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol (2005) 1.43
Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect Immun (2002) 1.43
Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling. PLoS One (2012) 1.42
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis (2007) 1.42